Učitavanje...
Sorafenib-induced tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma
Tumor lysis syndrome is a potentially lethal complication of chemotherapy, usually associated with aggressive hematologic malignancies. We describe the case of a young patient with metastatic hepatocellular cancer who developed rapid and fatal tumor lysis syndrome following initiation of sorafenib t...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2020-09-01
|
| Serija: | Hematology/Oncology and Stem Cell Therapy |
| Teme: | |
| Online pristup: | http://www.sciencedirect.com/science/article/pii/S1658387618300293 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|